Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
317 hedge funds and large institutions have $4.87B invested in Arena Pharmaceuticals Inc in 2021 Q4 according to their latest regulatory filings, with 120 funds opening new positions, 76 increasing their positions, 90 reducing their positions, and 35 closing their positions.
243% more first-time investments, than exits
New positions opened: 120 | Existing positions closed: 35
45% more capital invested
Capital invested by funds: $3.35B → $4.87B (+$1.52B)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
36% more call options, than puts
Call options by funds: $138M | Put options by funds: $101M
35% more funds holding
Funds holding: 235 → 317 (+82)
16% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$69.4M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$53.1M |
| 3 |
VI
Versor Investments
New York
|
+$51.1M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
+$50.2M |
| 5 |
Janus Henderson Group
London,
|
+$37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$295M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$144M |
| 3 |
Alkeon Capital Management
New York
|
-$104M |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$71.6M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$39.5M |
ARNA Hedge Fund Activity: Q4 2021 in Review
317 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2021, worth a combined $4.87B — up 45% from $3.35B a quarter earlier.
Buyers outnumbered sellers: 120 funds opened new ARNA positions and 35 closed out — a net gain of 85 holders — while 76 added to existing stakes and 90 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $69.4M. The largest seller was Wellington Management Group, cutting an estimated $295M.
- 317 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2021, up from 235 in Q3 2021.
- Funds reported $4.87B of Arena Pharmaceuticals Inc stock for Q4 2021, up 45% quarter-over-quarter.
- 120 funds opened new Arena Pharmaceuticals Inc positions in Q4 2021 and 35 closed out, a net change of +85 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2021 was Magnetar Financial, an estimated $69.4M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2021 was Wellington Management Group, an estimated $295M sold.
Based on aggregated 13F filings for Q4 2021.